PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Br J Ophthalmol. 2007 August; 91(8): 1016–1018.
Published online 2006 December 19. doi:  10.1136/bjo.2006.108829
PMCID: PMC1954836

Human papillomavirus and pterygium. Is the virus a risk factor?

Abstract

Background

Pterygium is a disease of unknown origin and pathogenesis that might be vision threatening. It is characterised by a wing‐like conjunctival overgrowth of the cornea. Several studies have investigated human papillomavirus (HPV) as a risk factor for the development of pterygia, but the results are inconclusive.

Aim

To investigate a large sample of pterygia for the presence of HPV in order to clarify the putative association between pterygia and HPV.

Methods

100 specimens of pterygium from Danish patients and 20 normal conjunctival biopsy specimens were investigated for the presence of HPV with PCR technique using β‐globin primers to access the quality of the extracted DNA and the HPV primers MY09/11 and GP5+/6+. HPV‐positive specimens underwent subsequent HPV typing with type‐specific HPV primers and further investigation with DNA in situ hybridisation (ISH).

Results

90 of 100 investigated pterygia proved suitable for HPV analysis by PCR. As β‐globin could not be amplified, 10 specimens were excluded from the study. 4 of 90 pterygia harboured HPV. HPV type 6 was identified in all four HPV‐positive pterygia. The 20 normal conjunctival biopsy specimens were β‐globin positive and HPV negative. All four pterygia that were HPV type 6 positive were DNA ISH negative.

Conclusions

The low presence of HPV DNA in pterygia does not support the hypothesis that HPV is involved in the development of pterygia in Denmark.

Pterygium is a disease of unknown origin and pathogenesis that might be vision threatening. The disease is characterised by a wing‐like conjunctival overgrowth of the cornea (fig 11).1 The overgrowth consists of a stromal part containing fibroblasts and blood vessels and is accompanied by an inflammatory cell infiltrate and an abnormal accumulation of extracellular matrix, which is composed of elastin and collagen1 (fig 11).). The stromal part is covered by flattened conjunctival epithelium (fig 11).). Bowman's layer beneath the pterygium may undergo destruction by the advancing fibrovascular tissue, resulting in a corneal scar. Pterygium is a common eye disease and has a worldwide distribution, occurring at highest prevalence and most severely in tropical regions. In Denmark, the prevalence of pterygium has been estimated to be 0.7%,2 whereas the prevalence was found to be 9.9% in Singapore3 and 23.4% among the coloured population of Barbados.4 Originally believed to be a degenerative condition of the conjunctiva, recent theories are considering pterygium as a growth disorder.5

figure bj108829.f1
Figure 1 (A) Pterygium characterised by a wing‐like conjunctival overgrowth of the cornea. (B) The basophilic appearance of elastotic degeneration is a characteristic feature of the stromal layer of pterygium. (H&E, ×100). ...

There is compelling epidemiological evidence that damage mediated by ultraviolet (UV) light acts as a trigger for the pathogenesis of pterygium.3,4,6,7,8,9 In accordance with this, a “two‐hit” theory has been suggested.10 Detorakis et al10 suggest that pterygium is caused due to a combination of an oncogenic agent and a pre‐existing genetic damage produced by UV light (or inherited factors).

Human papillomavirus (HPV) is composed of a closed circular double‐stranded DNA genome of which at least 100 different HPV genotypes are fully sequenced (http://www.stdgen.lanl.gov). The different HPV subtypes are associated with primarily benign or malignant epithelial tumours—for example, HPV 6 and 11 are associated with benign neoplasia and HPV 16 and 18 are closely linked with malignancy of the uterine cervical squamous epithelium.11 HPV is also associated with epithelial tumours of the conjunctiva, including conjunctival papilloma12 and conjunctival carcinoma.13 Several studies have investigated HPV as a risk factor for the development of pterygium, but the outcome seems inconclusive as the proportion of HPV‐positive pterygia ranges from 0% to 100%14,15,16,17 and the materials investigated were limited.

The purpose of the present study was to investigate a large material of pterygium for the presence of HPV in order to clarify the putative association between pterygium and HPV.

Materials and methods

In all, 100 specimens of primary pterygium from Danish patients registered during the period 1994–2003 were collected from the files of the Eye Pathology Institute, University of Copenhagen, Copenhagen, Denmark. Gender and age of patients were registered, and all material were reviewed histologically for the confirmation of the diagnosis. Furthermore, 20 normal conjunctival biopsy specimens excised during the years 2000–1 were included as controls.

Polymerase chain reaction

Three sections from each paraffin wax block were cut. The sections were placed in 1.5 ml tubes and 50 μl digestion buffer (10 mM Tris pH 7.0, 1 mM EDTA and K 200 μg/ml proteinase) was added. The specimens were digested at 65°C for 3 h, spinned and were transferred to a new tube for the aqueous phase. Boiling for 10 min inactivated the proteinase K. The samples, together with appropriate positive and negative controls, were amplified with primers targeting a 288 bp fragment of the single copy β‐globin gene in order to ensure the integrity of the DNA as described by Sebbelov et al.18 β‐Globin‐negative pterygia were excluded from further analysis.

HPV PCR was performed with the generally accepted consensus primers GP5+/GP6+19 and MY 09/1120; these primers amplify the majority of the known mucosa‐tropic HPV types. The PCR product, 15 μl, was run in a 1.5% submerged agarose gel in Tris‐acetate‐EDTA buffer, stained with ethidium bromide and viewed in UV transillumination. The sample was considered HPV positive when a band of a predicted size (~150 bp for the GP5+/GP6+ primers or 450 bp for the MY09/11 primers) was identified on the gel. HPV‐positive specimens underwent subsequent HPV typing with type‐specific HPV primers 6, 11, 16, 18, 31 and 33.21

DNA in situ hybridisation

HPV PCR‐positive pterygia and two HPV PCR‐negative conjunctival biopsy specimens were investigated with DNA in situ hybridisation (ISH). Sections of 5 μm thickness were cut and then immersed successively in toluene, 100%, 90%, 60% and 30% ethanol, and distilled water. For unmasking of nucleic acids, the specimens were treated with 50 μg/ml of proteinase K for 20 min at 37°C. Denaturation of target DNA and probe was achieved by heat treatment at 75°C for 10 min and 95°C for 5 min, respectively. Specimens were incubated with 50 ng/μl digoxigenin‐labelled HPV DNA probe 6, 11 or 16 at 37°C overnight. Sections were then subjected to two post‐hybridisation washes in standard saline citrate buffer and incubated in phosphate‐buffered saline containing 5% (weight/volume) bovine serum albumin. Thereafter, sections were incubated for 1 h with alkaline phosphatase conjugated anti‐digoxigenin 1/2000, followed by precipitation with nitroblue tetrazolium chloride and bromochloroindoylphosphate. Finally, sections were counterstained for 10 s in Mayers haematoxylin. Positive control sections were included in the experiment.

Results

Patient characteristics

The 100 patients consisted of 57 men and 43 women. Age range was 37–85 years, with a mean age of 63.4 years. All pterygia were primary lesions.

PCR results

In all, 90 of 100 investigated pterygia proved suitable for HPV analysis by PCR. As β‐globin could not be amplified in 10 specimens these were excluded from the study. In all, 4 of 90 pterygia harboured HPV. HPV type 6 was identified in all four HPV‐positive pterygia (fig 11).). All 20 normal conjunctival biopsy specimens were β‐globin positive and HPV negative.

DNA ISH results

The four pterygia that were HPV type 6 positive had been analysed using PCR investigations, and all were DNA ISH negative.

Discussion

UV light is associated with the development of pterygium,8 which is observed only in humans, and the lesion has never been described in animals. Therefore, risk factors other than UV radiation must be significant in the pathogenesis of pterygium. Our investigation of 100 pterygia questions the possibility that HPV is involved in the pathogenesis of pterygium. The low‐risk HPV type 6 was identified in only four specimens using the PCR technique. However, subsequent DNA ISH investigations were unable to confirm the presence of HPV. It is well known that the PCR technique is superior in sensitivity to the ISH technique.18,22 Therefore, the four HPV PCR‐positive but HPV DNA ISH‐negative specimens could be due to contamination of the investigated specimens or a non‐significant, incidental occurrence of an actual infection with a low number of virions. Nonetheless, owing to the small number of HPV‐positive pterygia in our material, it seems unlikely that HPV is an essential factor in the development of pterygia in Denmark.

Other investigations of pterygium have shown great geographical variance in the proportion of HPV‐positive pterygium.14,15,16,23,24 Using PCR, HPV was not identified in 65 pterygia from Taiwan14 and, likewise, Dushku et al24 were unable to detect HPV in an investigation of 13 pterygia in a study from the USA. On the other hand, 30% of pterygium from Greek patients were HPV positive23; in a British study,15 the HPV prevalence was 50% and Piras et al16 found HPV in 100% of 17 investigated Italian pterygia. However, none of the previous investigations have used immunohistochemistry or ISH to show the localisation of HPV in their HPV‐positive pterygia.15,16,23,24

A mechanism that might cause HPV to become undetectable by standard PCR assays is the integration of HPV DNA in the host cell genome in HPV‐positive tissue. Integration of HPV results in the interruption of HPV DNA in the early region of the genome.25 Nevertheless, previous studies performed on cervical carcinoma in The Netherlands indicate that this mechanism plays only a minor role.26 The pathogenesis of HPV infections might also support that HPV is not associated with pterygium. HPV infections are confined to the keratinocytes of the skin and mucosal surfaces.27 Therefore, the virus is highly adapted to this cell type and productive HPV infection is unlikely to occur in any other tissue types.27 Additionally, epidemiological data of pterygium prevalence and HPV infection contradict. The prevalence of pterygium increases linearly with age,3,4 whereas HPV infection is predominantly seen among younger people in their 20s and 30s.28 However, in recent years, new types of skin HPV have been identified and are more common than considered previously. These observations indicate that there is a reservoir of superficially located virus on the skin.29 Perhaps the different HPV frequencies in geographically distinct populations reflect that pterygium is a multifactorial disease resulting from a non‐specific response to various different insults. A number of proinflammatory cytokines, angiogenic and fibrogenic growth factors and their receptors have been reported in pterygium, which parallels their involvement in the corneal wound‐healing cascade.30,31 In particular, basic‐fibroblast growth factor, matrix metalloproteinases, vascular endothelial growth factor and heparin‐binding epidermal growth factor are over‐expressed in pterygium and, furthermore, directly or indirectly, induced by UV light.5,31 It has recently been shown that key proinflammatory cytokines and growth factors are modulated by exposure to UV light through intracellular pathways, which supports the role of cumulative UV damage in pterygium formation.31 Other postulated causative agents of this process include herpes virus23 and factors that cause repeated insults to the interpalpebral corneoscleral junction (eg, dust and wind exposure).1

In conclusion, our finding of the very limited presence of HPV DNA in pterygium does not support the hypothesis that HPV is involved in the development of pterygium in Denmark. The geographical variance in the proportion of HPV‐positive pterygium may reflect that pterygium is a multifactorial disease.

Acknowledgements

Landsforeningen Værn om Synet; The John and Birte Meyer Foundation; Betzy, Dagny og Caja Bojesens Mindefond; Synoptik Fonden; The Danish Eye Research Foundation and Michaelsen Fonden supported this study.

Abbreviations

HPV - human papillomavirus

ISH - in situ hybridisation

UV - ultraviolet

Footnotes

Competing interests: None declared.

References

1. Coroneo M T, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999. 10282–288.288. [PubMed]
2. Norn M S. Prevalence of pinguecula in Greenland and in Copenhagen, and its relation to pterygium and spheroid degeneration. Acta Ophthalmol (Copenh) 1979. 5796–105.105. [PubMed]
3. Wong T Y, Foster P J, Johnson G J. et al The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar Survey. Am J Ophthalmol 2001. 131176–183.183. [PubMed]
4. Luthra R, Nemesure B B, Wu S Y. et al Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol 2001. 1191827–1832.1832. [PubMed]
5. Di Girolamo N, Chui J, Coroneo M T. et al Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004. 23195–228.228. [PubMed]
6. Coroneo M T. Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol 1993. 77734–739.739. [PMC free article] [PubMed]
7. McCarty C A, Fu C L, Taylor H R. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000. 84289–292.292. [PMC free article] [PubMed]
8. Threlfall T J, English D R. Sun exposure and pterygium of the eye: a dose‐response curve. Am J Ophthalmol 1999. 128280–287.287. [PubMed]
9. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998. 26(Suppl 1)S2–S5.S5. [PubMed]
10. Detorakis E T, Drakonaki E E, Spandidos D A. Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 2000. 635–41.41. [PubMed]
11. Ylitalo N, Sorensen P, Josefsson A M. et al Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case–control study. Lancet 2000. 3552194–2198.2198. [PubMed]
12. Sjo N C, Heegaard S, Prause J U. et al Human papillomavirus in conjunctival papilloma. Br J Ophthalmol 2001. 85785–787.787. [PMC free article] [PubMed]
13. McDonnell J M, McDonnell P J, Sun Y Y. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci 1992. 33184–189.189. [PubMed]
14. Chen K H, Hsu W M, Cheng C C. et al Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol 2003. 871046–1048.1048. [PMC free article] [PubMed]
15. Gallagher M J, Giannoudis A, Herrington C S. et al Human papillomavirus in pterygium. Br J Ophthalmol 2001. 85782–784.784. [PMC free article] [PubMed]
16. Piras F, Moore P S, Ugalde J. et al Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003. 87864–866.866. [PMC free article] [PubMed]
17. Varinli S, Varinli I, Koksal E M. et al Human papillomavirus in pterygium. Cent Afr J Med 1994. 4024–26.26. [PubMed]
18. Sebbelov A M, Svendsen C, Jensen H. et al Prevalence of HPV in premalignant and malignant cervical lesions in Greenland and Denmark: PCR and in situ hybridization analysis on archival material. Res Virol 1994. 14583–92.92. [PubMed]
19. Roda Husman A M, Walboomers J M, van den Brule A J. et al The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995. 76(Pt 4)1057–1062.1062. [PubMed]
20. Manos M M, Ting Y, Wright D K. et al Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989. 7209–214.214.
21. van den Brule A J, Claas E C, du M M. et al Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol 1989. 2920–27.27. [PubMed]
22. Chardonnet Y, Lizard G, Chignol M C. et al Analytical methods for evaluation on whole cells of human papillomavirus infection. Bull Cancer 1995. 82107–113.113. [PubMed]
23. Detorakis E T, Sourvinos G, Spandidos D A. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 2001. 20164–167.167. [PubMed]
24. Dushku N, Hatcher S L, Albert D M. et al p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol 1999. 1171593–1599.1599. [PubMed]
25. Walboomers J M, Meijer C J. Do HPV‐negative cervical carcinomas exist? J Pathol 1997. 181253–254.254. [PubMed]
26. van den Brule A J, Walboomers J M, du M M. et al Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991. 48404–408.408. [PubMed]
27. Favre M, Ramoz N, Orth G. Human papillomaviruses: general features. Clin Dermatol 1997. 15181–198.198. [PubMed]
28. Kjaer S K, Lynge E. Incidence, prevalence and time trends of genital HPV infection determined by clinical examination and cytology. IARC Sci Publ 1989. 113–124.124.
29. Forslund O, Antonsson A, Nordin P. et al A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999. 80(Pt 9)2437–2443.2443. [PubMed]
30. Imanishi J, Kamiyama K, Iguchi I. et al Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000. 19113–129.129. [PubMed]
31. Di Girolamo N, Wakefield D, Coroneo M T. UVB‐mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006. 472430–2437.2437. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Group